Titan Biotech consolidated net profit rises 3.90% in the June 2024 quarter
Net profit of Titan Biotech rose 3.90% to Rs 6.40 crore in the quarter ended June 2024 as against Rs 6.16 crore during the previous quarter ended June 2023. Sales rose 24.06% to Rs 43.11 crore in the quarter ended June 2024 as against Rs 34.75 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 43.11 | 34.75 | 24 |
OPM % | 19.14 | 22.71 | - |
PBDT | 8.56 | 7.88 | 9 |
PBT | 7.52 | 7.09 | 6 |
NP | 6.40 | 6.16 | 4 |
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
₹0 Brokerage *
Open Demat Account